These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Immunoglobulin therapy of primary humoral immunologic deficiencies].
    Author: Bordigoni P.
    Journal: Rev Prat; 2007 Oct 15; 57(15):1691-8. PubMed ID: 18080428.
    Abstract:
    There is a strong body of evidence documenting that immunoglobulin therapy reduces the incidence and severity of infections in patients with primary humoral immunodeficiencies, whatever patient's age. Health-related quality of life is significantly improved in particular by self-infusions of subcutaneous immunoglobulins. Residual levels of total IgG over 6-800 mg/dL may help prevent progression of lung damage. Levels of IgG, clinical manifestations, pulmonary function tests and high resolution computed tomography routine surveillance is recommended.
    [Abstract] [Full Text] [Related] [New Search]